Characteristic | Oestrogen (n=50) | No treatment (n=50) | Overall (n=100) | |
Age, years* | <65 | 21 (42%) | 21 (42%) | 42 (42%) |
≥65 | 29 (58%) | 29 (58%) | 58 (58%) | |
Mean (SD) | 65.7 (8.2) | 65.9 (8.4) | 65.8 (8.3) | |
Ethnic group | White | 45 (90%) | 43 (86%) | 88 (88%) |
Asian | 2 (4%) | 3 (6%) | 5 (5%) | |
Black | 3 (6%) | 1 (2%) | 4 (4%) | |
Mixed | 0 (-) | 2 (4%) | 2 (5%) | |
Other ethnic group | 0 (-) | 1 (2%) | 1 (1%) | |
BMI (mg/k2) | Mean (SD) | 28.1 (5.1) | 28.2 (5.9) | 28.2 (5.5) |
Missing (N) | 2 | 7 | 9 | |
Parity* | ≤2 | 27 (54%) | 26 (52%) | 53 (53%) |
>2 | 23 (46%) | 24 (48%) | 47 (47%) | |
Maximum stage of prolapse* | I | 7 (14%) | 7 (14%) | 14 (14%) |
II | 23 (46%) | 23 (46%) | 46 (46%) | |
III/IV | 20 (40%) | 20 (40%) | 40 (40%) | |
Concomitant continence surgery performed* | N (%) | 2 (4%) | 3 (6%) | 5 (5%) |
Previous operation for prolapse | N (%) | 4 (8%) | 4 (8%) | 8 (8%) |
Anterior | No. of repairs, median (IQR) | 1 (1–1) | 1 (1–1) | 1 (1–1) |
Posterior | No. of repairs, median (IQR) | 1 (1–1) | 1 (1–1) | 1 (1–1) |
Hysterectomy | N (%) | 12 (24%) | 8 (16%) | 20 (20%) |
Vaginal pessary/ring currently in place | N (%) | 5 (10%) | 8 (16%) | 13 (13%) |
Physiotherapy treatment for prolapse/urinary incontinence in last 12 months | N (%) | 8 (16%) | 10 (20%) | 18 (18%) |
Drug treatment for urinary incontinence | N (%) | 0 (-) | 4 (8%) | 4 (4%) |
Treatment for overactive bladder | N (%) | 0 (-) | 0 (-) | 0 (-) |
*Minimisation variable.
BMI, body mass index.